Compare Pfizer with Abbott India - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs ABBOTT INDIA - Comparison Results

PFIZER     Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

ABBOTT INDIA 
   Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER ABBOTT INDIA PFIZER/
ABBOTT INDIA
 
P/E (TTM) x 32.6 48.0 67.9% View Chart
P/BV x 5.5 13.7 39.8% View Chart
Dividend Yield % 0.6 0.5 124.2%  

Financials

 PFIZER   ABBOTT INDIA
EQUITY SHARE DATA
    PFIZER
Mar-18
ABBOTT INDIA
Mar-18
PFIZER/
ABBOTT INDIA
5-Yr Chart
Click to enlarge
High Rs2,3656,110 38.7%   
Low Rs1,6253,996 40.7%   
Sales per share (Unadj.) Rs430.31,552.2 27.7%  
Earnings per share (Unadj.) Rs78.7188.8 41.7%  
Cash flow per share (Unadj.) Rs93.2196.4 47.4%  
Dividends per share (Unadj.) Rs20.0055.00 36.4%  
Dividend yield (eoy) %1.01.1 92.1%  
Book value per share (Unadj.) Rs586.5796.6 73.6%  
Shares outstanding (eoy) m45.7521.25 215.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.63.3 142.4%   
Avg P/E ratio x25.326.8 94.7%  
P/CF ratio (eoy) x21.425.7 83.2%  
Price / Book Value ratio x3.46.3 53.6%  
Dividend payout %25.429.1 87.2%   
Avg Mkt Cap Rs m91,271107,376 85.0%   
No. of employees `0002.63.3 79.2%   
Total wages/salary Rs m3,1433,937 79.8%   
Avg. sales/employee Rs Th7,484.89,929.3 75.4%   
Avg. wages/employee Rs Th1,195.01,185.1 100.8%   
Avg. net profit/employee Rs Th1,369.11,207.7 113.4%   
INCOME DATA
Net Sales Rs m19,68532,985 59.7%  
Other income Rs m1,1431,170 97.7%   
Total revenues Rs m20,82834,155 61.0%   
Gross profit Rs m5,0035,245 95.4%  
Depreciation Rs m663162 409.2%   
Interest Rs m438 11.0%   
Profit before tax Rs m5,4796,215 88.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8782,203 85.3%   
Profit after tax Rs m3,6014,012 89.7%  
Gross profit margin %25.415.9 159.8%  
Effective tax rate %34.335.4 96.7%   
Net profit margin %18.312.2 150.4%  
BALANCE SHEET DATA
Current assets Rs m24,16722,655 106.7%   
Current liabilities Rs m9,5446,681 142.9%   
Net working cap to sales %74.348.4 153.4%  
Current ratio x2.53.4 74.7%  
Inventory Days Days5565 85.0%  
Debtors Days Days2929 98.5%  
Net fixed assets Rs m9,514835 1,138.7%   
Share capital Rs m458213 215.3%   
"Free" reserves Rs m26,37516,715 157.8%   
Net worth Rs m26,83216,928 158.5%   
Long term debt Rs m250-   
Total assets Rs m36,90024,162 152.7%  
Interest coverage x1,305.5163.7 797.6%   
Debt to equity ratio x00-  
Sales to assets ratio x0.51.4 39.1%   
Return on assets %9.816.8 58.3%  
Return on equity %13.423.7 56.6%  
Return on capital %20.436.9 55.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m22369 6.1%   
Fx outflow Rs m1,4893,807 39.1%   
Net fx Rs m-1,466-3,438 42.6%   
CASH FLOW
From Operations Rs m3,3181,527 217.3%  
From Investments Rs m-2,383-2,148 110.9%  
From Financial Activity Rs m-1,104-1,024 107.7%  
Net Cashflow Rs m-169-1,646 10.2%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 63.9 75.0 85.2%  
Indian inst/Mut Fund % 7.5 7.9 94.9%  
FIIs % 4.9 0.1 4,900.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 17.1 138.6%  
Shareholders   85,207 18,270 466.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   CADILA HEALTHCARE  TTK HEALTHCARE  SHASUN PHARMA  DISHMAN PHARMA  J.B.CHEMICALS  

Compare PFIZER With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Trades in Green; Bajaj Finance and ICICI Bank Top Gainers(12:30 pm)

Stock markets in India are presently trading on a positive note. The BSE Sensex is trading up by 90 points and the NSE Nifty is trading up by 35 points.

Related Views on News

PFIZER Announces Quarterly Results (1QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PFIZER has posted a net profit of Rs 1 bn (up 22.8% YoY). Sales on the other hand came in at Rs 5 bn (up 6.3% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (1QFY20); Net Profit Up 41.9% (Quarterly Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

For the quarter ended June 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 41.9% YoY). Sales on the other hand came in at Rs 10 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

PFIZER Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, PFIZER has posted a net profit of Rs 1 bn (up 4.7% YoY). Sales on the other hand came in at Rs 5 bn (up 3.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Rebound Riches Could be Yours With These Stocks(Profit Hunter)

Oct 4, 2019

The secret to multibagger is not big businesses, but great managements... Here's how to find them to make the most of once in a decade rebound opportunity.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Oct 16, 2019 03:07 PM

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS